Lawton Alison Frances insider trades
Lawton Alison Frances has filed 10 Form 4s with the SEC that we hold, for Dianthus Therapeutics, Inc. /DE/ (DNTH) (Director), X4 Pharmaceuticals, Inc (XFOR) (Director) and Spyre Therapeutics, Inc. (AGLE) (Director). None of these filings reports a purchase (code P) or sale (code S) of common stock; they cover grants, option exercises and other codes. The first filing on our record is dated 2022-06-10 and the latest 2026-05-22.
Dianthus Therapeutics, Inc. /DE/ (DNTH)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
X4 Pharmaceuticals, Inc (XFOR)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Spyre Therapeutics, Inc. (AGLE)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1542650) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms